• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Analyst . Colorimetric reverse transcription loop-mediated isothermal amplification (RT-LAMP) as a visual diagnostic platform for the detection of

tetano

Editor, Senior Moderator
Analyst


. 2020 Nov 9.
doi: 10.1039/d0an01775b. Online ahead of print.
Colorimetric reverse transcription loop-mediated isothermal amplification (RT-LAMP) as a visual diagnostic platform for the detection of the emerging coronavirus SARS-CoV-2


Kawin Nawattanapaiboon[SUP] 1 [/SUP], Ekawat Pasomsub[SUP] 2 [/SUP], Photchanathorn Prombun[SUP] 3 [/SUP], Akanit Wongbunmak[SUP] 3 [/SUP], Akarawit Jenjitwanich[SUP] 3 [/SUP], Pantanat Mahasupachai[SUP] 3 [/SUP], Purichaya Vetcho[SUP] 3 [/SUP], Cholticha Chayrach[SUP] 3 [/SUP], Natthapon Manatjaroenlap[SUP] 3 [/SUP], Chonchanok Samphaongern[SUP] 3 [/SUP], Treewat Watthanachockchai[SUP] 2 [/SUP], Phonthanat Leedorkmai[SUP] 2 [/SUP], Suwimon Manopwisedjaroen[SUP] 4 [/SUP], Radeekorn Akkarawongsapat[SUP] 4 [/SUP], Arunee Thitithanyanont[SUP] 4 [/SUP], Matthew Phanchana[SUP] 5 [/SUP], Watanalai Panbangred[SUP] 6 [/SUP], Somchai Chauvatcharin[SUP] 7 [/SUP], Toemsak Srikhirin[SUP] 8 [/SUP]



Affiliations

Abstract

COVID-19, caused by the infection of SARS-CoV-2, has emerged as a rapidly spreading infection. The disease has now reached the level of a global pandemic and as a result a more rapid and simple detection method is imperative to curb the spread of the virus. We aimed to develop a visual diagnostic platform for SARS-CoV-2 based on colorimetric RT-LAMP with levels of sensitivity and specificity comparable to that of commercial qRT-PCR assays. In this work, the primers were designed to target a conserved region of the RNA-dependent RNA polymerase gene (RdRp). The assay was characterized for its sensitivity and specificity, and validated with clinical specimens collected in Thailand. The developed colorimetric RT-LAMP assay could amplify the target gene and enabled visual interpretation in 60 min at 65 ?C. No cross-reactivity with six other common human respiratory viruses (influenza A virus subtypes H1 and H3, influenza B virus, respiratory syncytial virus types A and B, and human metapneumovirus) and five other human coronaviruses (MERS-CoV, HKU-1, OC43, 229E and NL63) was observed. The limit of detection was 25 copies per reaction when evaluated with contrived specimens. However, the detection rate at this concentration fell to 95.8% when the incubation time was reduced from 60 to 30 min. The diagnostic performance of the developed RT-LAMP assay was evaluated in 2120 clinical specimens and compared with the commercial qRT-PCR. The results revealed high sensitivity and specificity of 95.74% and 99.95%, respectively. The overall accuracy of the RT-LAMP assay was determined to be 99.86%. In summary, our results indicate that the developed colorimetric RT-LAMP provides a simple, sensitive and reliable approach for the detection of SARS-CoV-2 in clinical samples, implying its beneficial use as a diagnostic platform for COVID-19 screening.
 
Back
Top Bottom